Eli Lilly, Amylin end collaboration, litigation – Yahoo Finance
INDIANAPOLIS (AP) -- Drugmakers Eli Lilly and Co. and Amylin Pharmaceuticals Inc. said Tuesday that they will end their long-standing collaboration to develop diabetes drugs, an announcement that sent Amylin shares tumbling. The companies also said they ...
Subscribe to LegalLaw247.Com Newsletter